Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
Main Authors: | Nicolas Prevel, Yves Allenbach, David Klatzmann, Benoit Salomon, Olivier Benveniste |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892965/?tool=EBI |
Similar Items
-
Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis.
by: Nicolas Prevel, et al.
Published: (2014-01-01) -
Beneficial role of rapamycin in experimental autoimmune myositis.
by: Nicolas Prevel, et al.
Published: (2013-01-01) -
Th1 response and systemic treg deficiency in inclusion body myositis.
by: Yves Allenbach, et al.
Published: (2014-01-01) -
Low dose rapamycin exacerbates autoimmune experimental uveitis.
by: Zili Zhang, et al.
Published: (2012-01-01) -
Statin-induced autoimmune necrotizing myositis
by: Katarzyna Ząber, et al.
Published: (2016-02-01)